The kidney in plasma cell dyscrasias
著者
書誌事項
The kidney in plasma cell dyscrasias
(Contributions to nephrology, v. 153)
Karger, 2007
大学図書館所蔵 全2件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and indexes
収録内容
- The kidney in plasma cell dyscrasias: a current view and a look at the future / Herrera, G.A.
- A history of the kidney in plasma cell disorders / Steensma, D.P., Kyle, R.A.
- Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias / Mayo, M.M., Schaef Johns, G.
- Mechanisms of renal damage in plasma cell dyscrasias: an overview / Merlini, G., Pozzi, C.
- Proximal tubular injury in myeloma / Batuman, V.
- Paraproteinemic renal diseases that involve the tubulo-interstitium / Herrera, G.A., Sanders, P.W.
- The mesangium as a target for glomerulopathic light and heavy chains: pathogenic considerations in light and heavy chain-mediated glomerular damage / Keeling, J., Herrera, G.A.
- Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis / Picken, M.M.
- Diversity and diversification of light chains in myeloma: the specter of amyloidogenesis by proxy / Gu, M., Wilton, R., Stevens, F.J.
- High-dose therapy in patients with plasma cell dyscrasias and renal dysfunction / Pineda-Roman, M., Tricot, G.
- Current and emerging views and treatments of systemic immunoglobulin light-chain (AL) amyloidosis / Comenzo, R.L.
内容説明・目次
内容説明
In recent years, the knowledge of how renal damage occurs in patients with plasma cell dyscrasias / myeloma has substantially increased. For the first time, this publication brings together issues relating to the diagnosis and pathogenesis of these disorders, as well as a summary of advances achieved in the treatment and management of patients. Several chapters are devoted to various glomerulopathies associated with deposition of immunoglobulin light and heavy chains, including those associated with amyloidosis. The sequential events are pointed out, crucial steps and key molecules open to modulation or control are delineated, and therapeutic advances are highlighted. Although the emphasis is on the management of cases with renal involvement, a distinct focus on the diseases as a whole and their impact on patients' general health and prognosis has been maintained throughout the discussions. Using a translational approach to renal manifestations in patients with plasma cell dyscrasias / myelomas, this publication conveys a comprehensive state-of-the-art view of the subject. It is aimed at practicing renal pathologists, nephrologists, internists and hematologists, as well as at trainees and scientists working in these specialties.
目次
- Introduction: The Kidney in Plasma Cell Dyscrasias: A Current View and a Look at the Future: Herrera, G.A.
- A History of the Kidney in Plasma Cell Disorders: Steensma, D.P.
- Kyle, R.A.
- Pathologic Studies Useful for the Diagnosis and Monitoring of Plasma Cell Dyscrasias: Veillon, D.M.
- Cotelingam, J.D.
- Serum Free Light Chains in the Diagnosis and Monitoring of Patients with Plasma Cell Dyscrasias: Mayo, M.M.
- Schaef Johns, G.
- Mechanisms of Renal Damage in Plasma Cell Dyscrasias: An Overview: Merlini, G.
- Pozzi, C.
- Proximal Tubular Injury in Myeloma: Batuman, V.
- Paraproteinemic Renal Diseases that Involve the Tubulo-Interstitium: Herrera, G.A.
- Sanders, P.W.
- The Mesangium as a Target for Glomerulopathic Light and Heavy Chains: Pathogenic Considerations in Light and Heavy Chain-Mediated Glomerular Damage: Keeling, J.
- Herrera, G.A.
- Immunoglobulin Light and Heavy Chain Amyloidosis AL/AH: Renal Pathology and Differential Diagnosis: Picken, M.M.
- Diversity and Diversification of Light Chains in Myeloma: The Specter of Amyloidogenesis by Proxy: Gu, M.
- Wilton, R.
- Stevens, F.J.
- High-Dose Therapy in Patients with Plasma Cell Dyscrasias and Renal Dysfunction: Pineda-Roman, M.
- Tricot, G.
- Current and Emerging Views and Treatments of Systemic Immunoglobulin Light-Chain (AL) Amyloidosis: Comenzo, R.L..
「Nielsen BookData」 より